Mantle Cell International Prognostic Index (MIPI) Is a Strong Predictor of the Outcome of Mantle Cell Lymphoma (MCL) in the Rituximab (R) Era.Annalisa Chiappella, Umberto Vitolo, Ileana Baldi et al.|Blood|2009Cited by 4
Validation of Mantle Cell International Prognostic Index (MIPI) in Mantle Cell Lymphoma (MCL) in a Retrospective Single Institution SeriesAnnalisa Chiappella, Umberto Vitolo, Barbara Botto et al.|Blood|2008Cited by 0
THE ROLE OF MANTLE CELL INTERNATIONAL PROGNOSTIC INDEX (MIPI) AS SURVIVAL PREDICTOR IN MANTLE CELL LYMPHOMA (MCL) PATIENTS TREATED WITH RITUXIMAB AND CHEMOTHERAPYAnnalisa Chiappella, Umberto Vitolo, Benedetta Puccini et al.|Unknown|2010Cited by 0